We are the only National Cancer Institute-designated "comprehensive" cancer center in inland Northern California. The 6 million people we serve live in one of the most ethnically diverse regions of the country. Driving new cancer discoveries is our mission and our clinical research moves breakthroughs quickly from the lab to the patient. The key points to know about us are that we:
Clinical Care
- Care for more than 100,000 adults and children each year
- Manage 200 adult and pediatric cancer clinical trials under way
- Create access to state-of-the-art care through our Cancer Care Network affiliations in Marysville, Truckee, Cameron Park, Chico and South Lake Tahoe
- Highly trained oncology-certified nurses
- Provide highly-trained oncology-certified nurses
Research
- Receive $50 million in research funding with nearly 260 scientists working on 300 + potential discoveries taking place within 43 university departments and seven schools, including the School of Veterinary Medicine
- Collaborate with JAX-West Laboratories to develop better research models for new therapies
- Participate in SCOPE: a city-wide phase I clinical research program offering novel therapies to patients throughout the region
- Conduct research, education and outreach to reduce vaccine-preventable cancers disproportionately affecting communities of color
- Lead in translational research, with achievements in:
- Combinatorial chemistry and novel nanotherapeutics for drug delivery and imaging
- Anti-androgen and other novel therapeutic approaches for advanced prostate cancer
- Basic science in DNA damage and repair and signal transduction
- Glycomics in cancer diagnosis, prognosis and imaging
- Biomedical technologies including EXPLORER, the world’s first total-body PET scanner
- Comparative oncology that treats pet dogs with novel cancer therapies that may help human patients